The global Treatment of Parathyroid Disease market was valued at US$ 1289.3 million in 2023 and is projected to reach US$ 1933.7 million by 2030, at a CAGR of 6.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Calcitriol Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Treatment of Parathyroid Disease include CTTQ, Roche, Future Health Pharma, KPC Pharmaceuticals, Teva Pharmaceutical, Nantong Huashan Pharmaceutical, Teijin Pharma, Kyowa Kirin and Cheplapharm Arzneimittel, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
The parathyroid glands are four small glands located in the neck that produce parathyroid hormone (PTH), which regulates the levels of calcium and phosphorus in the body. There are several drugs that can affect the function of the parathyroid gland or the levels of PTH in the body.
This report aims to provide a comprehensive presentation of the global market for Treatment of Parathyroid Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Treatment of Parathyroid Disease. This report contains market size and forecasts of Treatment of Parathyroid Disease in global, including the following market information:
- Global Treatment of Parathyroid Disease Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Treatment of Parathyroid Disease Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five Treatment of Parathyroid Disease companies in 2023 (%)
We surveyed the Treatment of Parathyroid Disease manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Treatment of Parathyroid Disease Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Treatment of Parathyroid Disease Market Segment Percentages, by Type, 2023 (%)
- Calcitriol
- Alfacalcidol
- Salmon Calcitonin
- Paricalcitol
- Other
Global Treatment of Parathyroid Disease Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Treatment of Parathyroid Disease Market Segment Percentages, by Application, 2023 (%)
Global Treatment of Parathyroid Disease Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Treatment of Parathyroid Disease Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Treatment of Parathyroid Disease revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Treatment of Parathyroid Disease revenues share in global market, 2023 (%)
- Key companies Treatment of Parathyroid Disease sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Treatment of Parathyroid Disease sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- CTTQ
- Roche
- Future Health Pharma
- KPC Pharmaceuticals
- Teva Pharmaceutical
- Nantong Huashan Pharmaceutical
- Teijin Pharma
- Kyowa Kirin
- Cheplapharm Arzneimittel
- Jiangsu Hengrui Pharmaceuticals
- Novartis
- Chongqing Yaoyou Pharmaceutical
- AbbVie
- Hebei Renhe Yikang Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Treatment of Parathyroid Disease, market overview.
Chapter 2: Global Treatment of Parathyroid Disease market size in revenue and volume.
Chapter 3: Detailed analysis of Treatment of Parathyroid Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Treatment of Parathyroid Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Treatment of Parathyroid Disease capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Treatment of Parathyroid Disease Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Treatment of Parathyroid Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Treatment of Parathyroid Disease Overall Market Size
2.1 Global Treatment of Parathyroid Disease Market Size: 2023 VS 2030
2.2 Global Treatment of Parathyroid Disease Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Treatment of Parathyroid Disease Sales: 2019-2030
3 Company Landscape
3.1 Top Treatment of Parathyroid Disease Players in Global Market
3.2 Top Global Treatment of Parathyroid Disease Companies Ranked by Revenue
3.3 Global Treatment of Parathyroid Disease Revenue by Companies
3.4 Global Treatment of Parathyroid Disease Sales by Companies
3.5 Global Treatment of Parathyroid Disease Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Treatment of Parathyroid Disease Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Treatment of Parathyroid Disease Product Type
3.8 Tier 1, Tier 2 and Tier 3 Treatment of Parathyroid Disease Players in Global Market
3.8.1 List of Global Tier 1 Treatment of Parathyroid Disease Companies
3.8.2 List of Global Tier 2 and Tier 3 Treatment of Parathyroid Disease Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Treatment of Parathyroid Disease Market Size Markets, 2023 & 2030
4.1.2 Calcitriol
4.1.3 Alfacalcidol
4.1.4 Salmon Calcitonin
4.1.5 Paricalcitol
4.1.6 Other
4.2 By Type - Global Treatment of Parathyroid Disease Revenue & Forecasts
4.2.1 By Type - Global Treatment of Parathyroid Disease Revenue, 2019-2024
4.2.2 By Type - Global Treatment of Parathyroid Disease Revenue, 2025-2030
4.2.3 By Type - Global Treatment of Parathyroid Disease Revenue Market Share, 2019-2030
4.3 By Type - Global Treatment of Parathyroid Disease Sales & Forecasts
4.3.1 By Type - Global Treatment of Parathyroid Disease Sales, 2019-2024
4.3.2 By Type - Global Treatment of Parathyroid Disease Sales, 2025-2030
4.3.3 By Type - Global Treatment of Parathyroid Disease Sales Market Share, 2019-2030
4.4 By Type - Global Treatment of Parathyroid Disease Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Treatment of Parathyroid Disease Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Treatment of Parathyroid Disease Revenue & Forecasts
5.2.1 By Application - Global Treatment of Parathyroid Disease Revenue, 2019-2024
5.2.2 By Application - Global Treatment of Parathyroid Disease Revenue, 2025-2030
5.2.3 By Application - Global Treatment of Parathyroid Disease Revenue Market Share, 2019-2030
5.3 By Application - Global Treatment of Parathyroid Disease Sales & Forecasts
5.3.1 By Application - Global Treatment of Parathyroid Disease Sales, 2019-2024
5.3.2 By Application - Global Treatment of Parathyroid Disease Sales, 2025-2030
5.3.3 By Application - Global Treatment of Parathyroid Disease Sales Market Share, 2019-2030
5.4 By Application - Global Treatment of Parathyroid Disease Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Treatment of Parathyroid Disease Market Size, 2023 & 2030
6.2 By Region - Global Treatment of Parathyroid Disease Revenue & Forecasts
6.2.1 By Region - Global Treatment of Parathyroid Disease Revenue, 2019-2024
6.2.2 By Region - Global Treatment of Parathyroid Disease Revenue, 2025-2030
6.2.3 By Region - Global Treatment of Parathyroid Disease Revenue Market Share, 2019-2030
6.3 By Region - Global Treatment of Parathyroid Disease Sales & Forecasts
6.3.1 By Region - Global Treatment of Parathyroid Disease Sales, 2019-2024
6.3.2 By Region - Global Treatment of Parathyroid Disease Sales, 2025-2030
6.3.3 By Region - Global Treatment of Parathyroid Disease Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Treatment of Parathyroid Disease Revenue, 2019-2030
6.4.2 By Country - North America Treatment of Parathyroid Disease Sales, 2019-2030
6.4.3 US Treatment of Parathyroid Disease Market Size, 2019-2030
6.4.4 Canada Treatment of Parathyroid Disease Market Size, 2019-2030
6.4.5 Mexico Treatment of Parathyroid Disease Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Treatment of Parathyroid Disease Revenue, 2019-2030
6.5.2 By Country - Europe Treatment of Parathyroid Disease Sales, 2019-2030
6.5.3 Germany Treatment of Parathyroid Disease Market Size, 2019-2030
6.5.4 France Treatment of Parathyroid Disease Market Size, 2019-2030
6.5.5 U.K. Treatment of Parathyroid Disease Market Size, 2019-2030
6.5.6 Italy Treatment of Parathyroid Disease Market Size, 2019-2030
6.5.7 Russia Treatment of Parathyroid Disease Market Size, 2019-2030
6.5.8 Nordic Countries Treatment of Parathyroid Disease Market Size, 2019-2030
6.5.9 Benelux Treatment of Parathyroid Disease Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Treatment of Parathyroid Disease Revenue, 2019-2030
6.6.2 By Region - Asia Treatment of Parathyroid Disease Sales, 2019-2030
6.6.3 China Treatment of Parathyroid Disease Market Size, 2019-2030
6.6.4 Japan Treatment of Parathyroid Disease Market Size, 2019-2030
6.6.5 South Korea Treatment of Parathyroid Disease Market Size, 2019-2030
6.6.6 Southeast Asia Treatment of Parathyroid Disease Market Size, 2019-2030
6.6.7 India Treatment of Parathyroid Disease Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Treatment of Parathyroid Disease Revenue, 2019-2030
6.7.2 By Country - South America Treatment of Parathyroid Disease Sales, 2019-2030
6.7.3 Brazil Treatment of Parathyroid Disease Market Size, 2019-2030
6.7.4 Argentina Treatment of Parathyroid Disease Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Treatment of Parathyroid Disease Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Treatment of Parathyroid Disease Sales, 2019-2030
6.8.3 Turkey Treatment of Parathyroid Disease Market Size, 2019-2030
6.8.4 Israel Treatment of Parathyroid Disease Market Size, 2019-2030
6.8.5 Saudi Arabia Treatment of Parathyroid Disease Market Size, 2019-2030
6.8.6 UAE Treatment of Parathyroid Disease Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 CTTQ
7.1.1 CTTQ Company Summary
7.1.2 CTTQ Business Overview
7.1.3 CTTQ Treatment of Parathyroid Disease Major Product Offerings
7.1.4 CTTQ Treatment of Parathyroid Disease Sales and Revenue in Global (2019-2024)
7.1.5 CTTQ Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Treatment of Parathyroid Disease Major Product Offerings
7.2.4 Roche Treatment of Parathyroid Disease Sales and Revenue in Global (2019-2024)
7.2.5 Roche Key News & Latest Developments
7.3 Future Health Pharma
7.3.1 Future Health Pharma Company Summary
7.3.2 Future Health Pharma Business Overview
7.3.3 Future Health Pharma Treatment of Parathyroid Disease Major Product Offerings
7.3.4 Future Health Pharma Treatment of Parathyroid Disease Sales and Revenue in Global (2019-2024)
7.3.5 Future Health Pharma Key News & Latest Developments
7.4 KPC Pharmaceuticals
7.4.1 KPC Pharmaceuticals Company Summary
7.4.2 KPC Pharmaceuticals Business Overview
7.4.3 KPC Pharmaceuticals Treatment of Parathyroid Disease Major Product Offerings
7.4.4 KPC Pharmaceuticals Treatment of Parathyroid Disease Sales and Revenue in Global (2019-2024)
7.4.5 KPC Pharmaceuticals Key News & Latest Developments
7.5 Teva Pharmaceutical
7.5.1 Teva Pharmaceutical Company Summary
7.5.2 Teva Pharmaceutical Business Overview
7.5.3 Teva Pharmaceutical Treatment of Parathyroid Disease Major Product Offerings
7.5.4 Teva Pharmaceutical Treatment of Parathyroid Disease Sales and Revenue in Global (2019-2024)
7.5.5 Teva Pharmaceutical Key News & Latest Developments
7.6 Nantong Huashan Pharmaceutical
7.6.1 Nantong Huashan Pharmaceutical Company Summary
7.6.2 Nantong Huashan Pharmaceutical Business Overview
7.6.3 Nantong Huashan Pharmaceutical Treatment of Parathyroid Disease Major Product Offerings
7.6.4 Nantong Huashan Pharmaceutical Treatment of Parathyroid Disease Sales and Revenue in Global (2019-2024)
7.6.5 Nantong Huashan Pharmaceutical Key News & Latest Developments
7.7 Teijin Pharma
7.7.1 Teijin Pharma Company Summary
7.7.2 Teijin Pharma Business Overview
7.7.3 Teijin Pharma Treatment of Parathyroid Disease Major Product Offerings
7.7.4 Teijin Pharma Treatment of Parathyroid Disease Sales and Revenue in Global (2019-2024)
7.7.5 Teijin Pharma Key News & Latest Developments
7.8 Kyowa Kirin
7.8.1 Kyowa Kirin Company Summary
7.8.2 Kyowa Kirin Business Overview
7.8.3 Kyowa Kirin Treatment of Parathyroid Disease Major Product Offerings
7.8.4 Kyowa Kirin Treatment of Parathyroid Disease Sales and Revenue in Global (2019-2024)
7.8.5 Kyowa Kirin Key News & Latest Developments
7.9 Cheplapharm Arzneimittel
7.9.1 Cheplapharm Arzneimittel Company Summary
7.9.2 Cheplapharm Arzneimittel Business Overview
7.9.3 Cheplapharm Arzneimittel Treatment of Parathyroid Disease Major Product Offerings
7.9.4 Cheplapharm Arzneimittel Treatment of Parathyroid Disease Sales and Revenue in Global (2019-2024)
7.9.5 Cheplapharm Arzneimittel Key News & Latest Developments
7.10 Jiangsu Hengrui Pharmaceuticals
7.10.1 Jiangsu Hengrui Pharmaceuticals Company Summary
7.10.2 Jiangsu Hengrui Pharmaceuticals Business Overview
7.10.3 Jiangsu Hengrui Pharmaceuticals Treatment of Parathyroid Disease Major Product Offerings
7.10.4 Jiangsu Hengrui Pharmaceuticals Treatment of Parathyroid Disease Sales and Revenue in Global (2019-2024)
7.10.5 Jiangsu Hengrui Pharmaceuticals Key News & Latest Developments
7.11 Novartis
7.11.1 Novartis Company Summary
7.11.2 Novartis Treatment of Parathyroid Disease Business Overview
7.11.3 Novartis Treatment of Parathyroid Disease Major Product Offerings
7.11.4 Novartis Treatment of Parathyroid Disease Sales and Revenue in Global (2019-2024)
7.11.5 Novartis Key News & Latest Developments
7.12 Chongqing Yaoyou Pharmaceutical
7.12.1 Chongqing Yaoyou Pharmaceutical Company Summary
7.12.2 Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Business Overview
7.12.3 Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Major Product Offerings
7.12.4 Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Sales and Revenue in Global (2019-2024)
7.12.5 Chongqing Yaoyou Pharmaceutical Key News & Latest Developments
7.13 AbbVie
7.13.1 AbbVie Company Summary
7.13.2 AbbVie Treatment of Parathyroid Disease Business Overview
7.13.3 AbbVie Treatment of Parathyroid Disease Major Product Offerings
7.13.4 AbbVie Treatment of Parathyroid Disease Sales and Revenue in Global (2019-2024)
7.13.5 AbbVie Key News & Latest Developments
7.14 Hebei Renhe Yikang Pharmaceutical
7.14.1 Hebei Renhe Yikang Pharmaceutical Company Summary
7.14.2 Hebei Renhe Yikang Pharmaceutical Business Overview
7.14.3 Hebei Renhe Yikang Pharmaceutical Treatment of Parathyroid Disease Major Product Offerings
7.14.4 Hebei Renhe Yikang Pharmaceutical Treatment of Parathyroid Disease Sales and Revenue in Global (2019-2024)
7.14.5 Hebei Renhe Yikang Pharmaceutical Key News & Latest Developments
8 Global Treatment of Parathyroid Disease Production Capacity, Analysis
8.1 Global Treatment of Parathyroid Disease Production Capacity, 2019-2030
8.2 Treatment of Parathyroid Disease Production Capacity of Key Manufacturers in Global Market
8.3 Global Treatment of Parathyroid Disease Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Treatment of Parathyroid Disease Supply Chain Analysis
10.1 Treatment of Parathyroid Disease Industry Value Chain
10.2 Treatment of Parathyroid Disease Upstream Market
10.3 Treatment of Parathyroid Disease Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Treatment of Parathyroid Disease Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Treatment of Parathyroid Disease in Global Market
Table 2. Top Treatment of Parathyroid Disease Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Treatment of Parathyroid Disease Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Treatment of Parathyroid Disease Revenue Share by Companies, 2019-2024
Table 5. Global Treatment of Parathyroid Disease Sales by Companies, (K Units), 2019-2024
Table 6. Global Treatment of Parathyroid Disease Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Treatment of Parathyroid Disease Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Treatment of Parathyroid Disease Product Type
Table 9. List of Global Tier 1 Treatment of Parathyroid Disease Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Treatment of Parathyroid Disease Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Treatment of Parathyroid Disease Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Treatment of Parathyroid Disease Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Treatment of Parathyroid Disease Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Treatment of Parathyroid Disease Sales (K Units), 2019-2024
Table 15. By Type - Global Treatment of Parathyroid Disease Sales (K Units), 2025-2030
Table 16. By Application ? Global Treatment of Parathyroid Disease Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Treatment of Parathyroid Disease Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Treatment of Parathyroid Disease Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Treatment of Parathyroid Disease Sales (K Units), 2019-2024
Table 20. By Application - Global Treatment of Parathyroid Disease Sales (K Units), 2025-2030
Table 21. By Region ? Global Treatment of Parathyroid Disease Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Treatment of Parathyroid Disease Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Treatment of Parathyroid Disease Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Treatment of Parathyroid Disease Sales (K Units), 2019-2024
Table 25. By Region - Global Treatment of Parathyroid Disease Sales (K Units), 2025-2030
Table 26. By Country - North America Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Treatment of Parathyroid Disease Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Treatment of Parathyroid Disease Sales, (K Units), 2019-2024
Table 29. By Country - North America Treatment of Parathyroid Disease Sales, (K Units), 2025-2030
Table 30. By Country - Europe Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Treatment of Parathyroid Disease Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Treatment of Parathyroid Disease Sales, (K Units), 2019-2024
Table 33. By Country - Europe Treatment of Parathyroid Disease Sales, (K Units), 2025-2030
Table 34. By Region - Asia Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Treatment of Parathyroid Disease Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Treatment of Parathyroid Disease Sales, (K Units), 2019-2024
Table 37. By Region - Asia Treatment of Parathyroid Disease Sales, (K Units), 2025-2030
Table 38. By Country - South America Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Treatment of Parathyroid Disease Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Treatment of Parathyroid Disease Sales, (K Units), 2019-2024
Table 41. By Country - South America Treatment of Parathyroid Disease Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Treatment of Parathyroid Disease Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Treatment of Parathyroid Disease Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Treatment of Parathyroid Disease Sales, (K Units), 2025-2030
Table 46. CTTQ Company Summary
Table 47. CTTQ Treatment of Parathyroid Disease Product Offerings
Table 48. CTTQ Treatment of Parathyroid Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. CTTQ Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche Treatment of Parathyroid Disease Product Offerings
Table 52. Roche Treatment of Parathyroid Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Roche Key News & Latest Developments
Table 54. Future Health Pharma Company Summary
Table 55. Future Health Pharma Treatment of Parathyroid Disease Product Offerings
Table 56. Future Health Pharma Treatment of Parathyroid Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Future Health Pharma Key News & Latest Developments
Table 58. KPC Pharmaceuticals Company Summary
Table 59. KPC Pharmaceuticals Treatment of Parathyroid Disease Product Offerings
Table 60. KPC Pharmaceuticals Treatment of Parathyroid Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. KPC Pharmaceuticals Key News & Latest Developments
Table 62. Teva Pharmaceutical Company Summary
Table 63. Teva Pharmaceutical Treatment of Parathyroid Disease Product Offerings
Table 64. Teva Pharmaceutical Treatment of Parathyroid Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Teva Pharmaceutical Key News & Latest Developments
Table 66. Nantong Huashan Pharmaceutical Company Summary
Table 67. Nantong Huashan Pharmaceutical Treatment of Parathyroid Disease Product Offerings
Table 68. Nantong Huashan Pharmaceutical Treatment of Parathyroid Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Nantong Huashan Pharmaceutical Key News & Latest Developments
Table 70. Teijin Pharma Company Summary
Table 71. Teijin Pharma Treatment of Parathyroid Disease Product Offerings
Table 72. Teijin Pharma Treatment of Parathyroid Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Teijin Pharma Key News & Latest Developments
Table 74. Kyowa Kirin Company Summary
Table 75. Kyowa Kirin Treatment of Parathyroid Disease Product Offerings
Table 76. Kyowa Kirin Treatment of Parathyroid Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Kyowa Kirin Key News & Latest Developments
Table 78. Cheplapharm Arzneimittel Company Summary
Table 79. Cheplapharm Arzneimittel Treatment of Parathyroid Disease Product Offerings
Table 80. Cheplapharm Arzneimittel Treatment of Parathyroid Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Cheplapharm Arzneimittel Key News & Latest Developments
Table 82. Jiangsu Hengrui Pharmaceuticals Company Summary
Table 83. Jiangsu Hengrui Pharmaceuticals Treatment of Parathyroid Disease Product Offerings
Table 84. Jiangsu Hengrui Pharmaceuticals Treatment of Parathyroid Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Jiangsu Hengrui Pharmaceuticals Key News & Latest Developments
Table 86. Novartis Company Summary
Table 87. Novartis Treatment of Parathyroid Disease Product Offerings
Table 88. Novartis Treatment of Parathyroid Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Novartis Key News & Latest Developments
Table 90. Chongqing Yaoyou Pharmaceutical Company Summary
Table 91. Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Product Offerings
Table 92. Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Chongqing Yaoyou Pharmaceutical Key News & Latest Developments
Table 94. AbbVie Company Summary
Table 95. AbbVie Treatment of Parathyroid Disease Product Offerings
Table 96. AbbVie Treatment of Parathyroid Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. AbbVie Key News & Latest Developments
Table 98. Hebei Renhe Yikang Pharmaceutical Company Summary
Table 99. Hebei Renhe Yikang Pharmaceutical Treatment of Parathyroid Disease Product Offerings
Table 100. Hebei Renhe Yikang Pharmaceutical Treatment of Parathyroid Disease Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Hebei Renhe Yikang Pharmaceutical Key News & Latest Developments
Table 102. Treatment of Parathyroid Disease Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 103. Global Treatment of Parathyroid Disease Capacity Market Share of Key Manufacturers, 2021-2024
Table 104. Global Treatment of Parathyroid Disease Production by Region, 2019-2024 (K Units)
Table 105. Global Treatment of Parathyroid Disease Production by Region, 2025-2030 (K Units)
Table 106. Treatment of Parathyroid Disease Market Opportunities & Trends in Global Market
Table 107. Treatment of Parathyroid Disease Market Drivers in Global Market
Table 108. Treatment of Parathyroid Disease Market Restraints in Global Market
Table 109. Treatment of Parathyroid Disease Raw Materials
Table 110. Treatment of Parathyroid Disease Raw Materials Suppliers in Global Market
Table 111. Typical Treatment of Parathyroid Disease Downstream
Table 112. Treatment of Parathyroid Disease Downstream Clients in Global Market
Table 113. Treatment of Parathyroid Disease Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Treatment of Parathyroid Disease Segment by Type in 2023
Figure 2. Treatment of Parathyroid Disease Segment by Application in 2023
Figure 3. Global Treatment of Parathyroid Disease Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Treatment of Parathyroid Disease Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Treatment of Parathyroid Disease Revenue, 2019-2030 (US$, Mn)
Figure 7. Treatment of Parathyroid Disease Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Treatment of Parathyroid Disease Revenue in 2023
Figure 9. By Type - Global Treatment of Parathyroid Disease Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Treatment of Parathyroid Disease Revenue Market Share, 2019-2030
Figure 11. By Type - Global Treatment of Parathyroid Disease Sales Market Share, 2019-2030
Figure 12. By Type - Global Treatment of Parathyroid Disease Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Treatment of Parathyroid Disease Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Treatment of Parathyroid Disease Revenue Market Share, 2019-2030
Figure 15. By Application - Global Treatment of Parathyroid Disease Sales Market Share, 2019-2030
Figure 16. By Application - Global Treatment of Parathyroid Disease Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Treatment of Parathyroid Disease Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Treatment of Parathyroid Disease Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Treatment of Parathyroid Disease Revenue Market Share, 2019-2030
Figure 20. By Region - Global Treatment of Parathyroid Disease Sales Market Share, 2019-2030
Figure 21. By Country - North America Treatment of Parathyroid Disease Revenue Market Share, 2019-2030
Figure 22. By Country - North America Treatment of Parathyroid Disease Sales Market Share, 2019-2030
Figure 23. US Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Treatment of Parathyroid Disease Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Treatment of Parathyroid Disease Sales Market Share, 2019-2030
Figure 28. Germany Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 29. France Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Treatment of Parathyroid Disease Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Treatment of Parathyroid Disease Sales Market Share, 2019-2030
Figure 37. China Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 41. India Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Treatment of Parathyroid Disease Revenue Market Share, 2019-2030
Figure 43. By Country - South America Treatment of Parathyroid Disease Sales Market Share, 2019-2030
Figure 44. Brazil Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Treatment of Parathyroid Disease Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Treatment of Parathyroid Disease Sales Market Share, 2019-2030
Figure 48. Turkey Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Treatment of Parathyroid Disease Revenue, (US$, Mn), 2019-2030
Figure 52. Global Treatment of Parathyroid Disease Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Treatment of Parathyroid Disease by Region, 2023 VS 2030
Figure 54. Treatment of Parathyroid Disease Industry Value Chain
Figure 55. Marketing Channels
